(Q41830673)

12 October 2017

Histone variant H2A.Z.2: A novel driver of melanoma progression (English)

1 reference

12 October 2017

Chiara Vardabasso

1

1 reference

PMCID

4905390

12 October 2017

Sandra B Hake

series ordinal

2

1 reference

PMCID

4905390

12 October 2017

Emily Bernstein

series ordinal

3

1 reference

12 October 2017

16 September 2015

1 reference

Molecular & cellular oncology

12 October 2017

1 reference

12 October 2017

3

1 reference

12 October 2017

2

1 reference

12 October 2017

e1073417

1 reference

Genomic Classification of Cutaneous Melanoma

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

Decreased expression of the chromatin remodeler ATRX associates with melanoma progression

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

Tumor adaptation and resistance to RAF inhibitors

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

Histone variants: emerging players in cancer biology

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

BET domain co-regulators in obesity, inflammation and cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

The histone variant macroH2A suppresses melanoma progression through regulation of CDK8.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

Selective inhibition of BET bromodomains

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905390

10.1080/23723556.2015.1073417

18 August 2018

Identifiers

DOI

1 reference

12 October 2017

1 reference

12 October 2017

1 reference

PMCID

4905390